Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LINEZOLID (FORM-II), with a corresponding US DMF Number 28642.
Remarkably, this DMF maintains an Active status since its submission on September 16, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2015, and payment made on October 29, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II